Trial Profile
Efficacy of vonoprazan in patients with gastroesophageal reflux disease refractory to proton pump inhibitors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Erosive oesophagitis; Gastro-oesophageal reflux
- Focus Therapeutic Use
- 15 Dec 2016 New trial record
- 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week